85 related articles for article (PubMed ID: 10215655)
1. Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy.
Serkova N; Litt L; James TL; Sadée W; Leibfritz D; Benet LZ; Christians U
J Pharmacol Exp Ther; 1999 May; 289(2):800-6. PubMed ID: 10215655
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the mechanism of astrocyte swelling induced by the macrolide immunosuppressant sirolimus using multinuclear nuclear magnetic resonance spectroscopy.
Serkova N; Christians U; Flögel U; Pfeuffer J; Leibfritz D
Chem Res Toxicol; 1997 Dec; 10(12):1359-63. PubMed ID: 9437526
[TBL] [Abstract][Full Text] [Related]
3. Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism.
Gottschalk S; Cummins CL; Leibfritz D; Christians U; Benet LZ; Serkova NJ
Neurotoxicology; 2011 Jan; 32(1):50-7. PubMed ID: 21075140
[TBL] [Abstract][Full Text] [Related]
4. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
[TBL] [Abstract][Full Text] [Related]
5. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.
Christians U; Gottschalk S; Miljus J; Hainz C; Benet LZ; Leibfritz D; Serkova N
Br J Pharmacol; 2004 Oct; 143(3):388-96. PubMed ID: 15339861
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
Serkova N; Hausen B; Berry GJ; Jacobsen W; Benet LZ; Morris RE; Christians U
J Pharmacol Exp Ther; 2000 Jul; 294(1):323-32. PubMed ID: 10871329
[TBL] [Abstract][Full Text] [Related]
7. Biochemical mechanisms of cyclosporine neurotoxicity.
Serkova NJ; Christians U; Benet LZ
Mol Interv; 2004 Apr; 4(2):97-107. PubMed ID: 15087483
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress-induced metabolic alterations in rat brain astrocytes studied by multinuclear NMR spectroscopy.
Brand A; Leibfritz D; Richter-Landsberg C
J Neurosci Res; 1999 Nov; 58(4):576-85. PubMed ID: 10533049
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus/cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model.
Deters M; Klabunde T; Kirchner G; Resch K; Kaever V
Br J Pharmacol; 2002 Jun; 136(4):604-12. PubMed ID: 12055139
[TBL] [Abstract][Full Text] [Related]
10. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain.
Serkova N; Jacobsen W; Niemann CU; Litt L; Benet LZ; Leibfritz D; Christians U
Br J Pharmacol; 2001 Jul; 133(6):875-85. PubMed ID: 11454661
[TBL] [Abstract][Full Text] [Related]
12. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
[TBL] [Abstract][Full Text] [Related]
13. Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function.
Klawitter J; Bendrick-Peart J; Rudolph B; Beckey V; Klawitter J; Haschke M; Rivard C; Chan L; Leibfritz D; Christians U; Schmitz V
Chem Res Toxicol; 2009 Jan; 22(1):118-28. PubMed ID: 19099400
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
[TBL] [Abstract][Full Text] [Related]
15. Energy metabolism in astrocytes and neurons treated with manganese: relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis.
Zwingmann C; Leibfritz D; Hazell AS
J Cereb Blood Flow Metab; 2003 Jun; 23(6):756-71. PubMed ID: 12796724
[TBL] [Abstract][Full Text] [Related]
16. Median effect analysis of efficacy versus adverse effects of immunosuppressants.
Kahan BD; Kramer WG
Clin Pharmacol Ther; 2001 Jul; 70(1):74-81. PubMed ID: 11452247
[TBL] [Abstract][Full Text] [Related]
17. The relative proportions of sirolimus metabolites in blood using HPLC with mass-spectrometric detection.
Holt DW; McKeown DA; Lee TD; Hicks D; Cal P; Johnston A
Transplant Proc; 2004 Dec; 36(10):3223-5. PubMed ID: 15686732
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism.
Klawitter J; Gottschalk S; Hainz C; Leibfritz D; Christians U; Serkova NJ
Chem Res Toxicol; 2010 Mar; 23(3):608-19. PubMed ID: 20148532
[TBL] [Abstract][Full Text] [Related]
19. Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimen.
Kahan BD; Podbielski J; Schoenberg L
Transplant Proc; 2006 Nov; 38(9):2842-6. PubMed ID: 17112844
[TBL] [Abstract][Full Text] [Related]
20. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
